Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Anaesthesiology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Anaesthesiology Other
    Melatonin Reduces Emergence Delirium Post-Anaesthesia in Children - (DGNews)
    Ketamine Is a Safe Alternative Sedative to Etomidate When Intubating Critically Ill Patients - (DGNews)
    Deep Sedation Results in Greater Polyp Yield During Colonoscopy: Presented at DDW - (DGDispatch)
    Diclofenac Sodium 1% Gel Appears Safe, Effective for Knee Osteoarthritis: Presented at APS - (DGDispatch)
    Conservative Blood Glucose Control May Improve Outcomes for Vascular Surgery Patients - (DGNews)

    News archive

     Recent webcasts/CME - Anaesthesiology Other
    • Practical Considerations in Management of Chronic Pain
    • Overview of Chronic Pain: Practical Definitions and Characteristics
    • An Interdisciplinary Approach to Chronic Pain: Improving Outcomes by Overcoming Therapeutic Barriers
    • Defeating Normal Thermoregulatory Defenses: Induction of Therapeutic Hypothermia
      Perioperative Heat Balance

      Webcasts/CME archive

       Recent cases - Anaesthesiology Other
        Anaesthetic Management of an Adult Patient with DOOR Syndrome: A Case Report
        Massive Facial Edema and Airway Obstruction Secondary to Acute Postoperative Sialadenitis or "Anesthesia Mumps": A Case Report
        Anaesthesia for Serial Whole-Lung Lavage in a Patient with Severe Pulmonary Alveolar Proteinosis: A Case Report
        Anesthetic Management of a Patient with Prosthetic Heart Valve for Non-Cardiac Surgery: A Case Report
        Arytenoid Dislocation Related to an Uneventful Endotracheal Intubation: A Case Report

        Cases archive
          




        my personal edition > anaesthesiology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        New Options for Better Control of Blood Loss in Neurosurgical Patients: Presented at ASA

        By Arushi Sinha, PhD

        SAN FRANCISO, CA -- October 19, 2007 -- Use of activated factor VIIa (FVIIa) appears to decrease the need for blood transfusions during surgery in patients with traumatic brain injuries (TBI), according to a study presented here at the Annual Meeting of the American Society of Anesthesiologists (ASA).

        Surgical treatment of patients with coagulopathies has always presented a challenge, according to the study researchers, led by Trung Vu, MD, Third-Year Resident, MD, Associate Professor, Division of Trauma Anaesthesiology, University of Maryland Medical System, Baltimore, Maryland, United States. Difficulties in establishing normal coagulation can delay surgery, while performing surgery in patients with coagulopathies can result in substantial intraoperative blood loss.

        FVIIa is a potent procoagulant agent that promotes haemostasis. Activated FVIIa was developed to treat haemophiliacs, but in recent years it has been suggested that this agent could be used for rapid correction of coagulopathy and to decrease perioperative bleeding.

        Therefore, Dr. Vu and colleagues conducted their study to examine the role of activated FVIIa in decreasing the need for transfusion during neurosurgery in patients with TBI.

        The researchers designed a retrospective study of 57 TBI patients who received activated FVIIa either before or during the surgical procedure. A control group sample was comprised of the same number of patients undergoing neurosurgery for TBI who did not receive activated FVIIa.

        For the purposes of this study, blood products were defined as packed red blood cells (pRBC) or fresh frozen plasma (FFP).

        Results show that the patients who received activated FVIIa received 2.3 units of pRBC and 3.5 units of FFP, while the control group patients received 10 units of pRBC and 24.9 units of FFP, a significant difference (P <.0001).

        "FVIIa does decrease the use of FPP and other blood products," Dr. Vu said.

        "The most significant finding is that [activated] FVIIa was used for haemophiliacs in the past and today it may be used for severe intraoperative bleeding when we have trouble controlling haemorrhaging shock," explained Dr. Vu.

        "We did not find any significant difference in ICU stay, hospital stay, or mortality," He added.

        Based on these results, the team concluded that the use of activated FVIIa decreased the need for the perioperative transfusion among neurosurgical patients with TBI.

        Therefore, the researchers urge further study of this agent as a means for more effective surgical outcomes in TBI patients.


        [Presentation title: Factor VIIa Decreases Transfusion in Patients With Traumatic Brain Injury Undergoing Craniotomy. Abstract A1081]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send